Opinion
SKVARLA: North Carolina Medicare enrollees and innovation will be hurt by new drug pricing policy
A proposed revision in drug pricing policy could negatively impact one of North Carolina’s most important industries as well as patients — especially the nearly 2 million North Carolina seniors and people with serious medical issues who […]